Touchlight DNA Services Ltd
- CMO, CRO
- Biotech or pharma, therapeutic R&D
Touchlight has pioneered enzymatic DNA to enable advanced therapy medicine development and commercialisation. Touchlight's synthetic DNA is in clinical studies with partners across mRNA, AAV, genome edited cell therapy and DNA vaccines & the company has license agreements with Pfizer and GSK.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}